Tevogen Founder Reflects On Importance Of Preserving Shareholder Value While Navigating Growth As It Prepares To File Quarterly Financials
Tevogen is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen's leadership believes that ...
Akoya Biosciences Reports Third Quarter 2024 Financial Results
For the third quarter of 2024, revenue was $18.8 million, a 25% year-over-year decrease from $25.2 million in the third quarter of 2023. For the third quarter of 2024, gross margin was 62.3%, an ...